In a rare move, maker of failed ALS drug removes it from the market
Daniel Gilbert
Amylyx Pharmaceuticals said it would voluntarily remove its FDA-approved drug for amyotrophic lateral sclerosis from the market after a trial showed it doesn't work.
Work Advice: Is that chill in the air retaliation from my employer?
Karla Miller
A worker is noticing a change in co-workers' behavior and has been passed up for a project. Could it be retaliation for a complaint filed months ago?
Can kosher food be hip? Manischewitz is betting its rebrand on it.
Jaclyn Peiser
The 136-year-old brand known for its Passover offerings hopes its revamp will appeal to the culturally curious.
In a first, FDA authorizes AI-driven test to predict sepsis in hospitals
Daniel Gilbert, Rachel Roubein
Prenosis, an artificial intelligence company, developed a tool to predict patients' risk of developing sepsis, which contributes to at least 350,000 U.S. deaths a year.
To comply with court, federal agency lets White people claim social disadvantage
Julian Mark
The Minority Business Development Agency now extends services to entrepreneurs of any race who identify as disadvantaged on a federal form.
Women's share of executive jobs falls for first time in years, study finds
Taylor Telford
Researchers at S&P Global Market Intelligence see it as an "alarming turning point" for gender parity in corporate America.